“…Despite the large diversity of mutation patterns globally, only few specific mutations are predominant (Table 2) (Sandgren et al., 2009; Zhang & Yew, 2015). For instance, in the case of rifampicin resistance, hundreds of rpo B mutations have been described (not all were associated with rifampicin resistance), but more than 80% of rifampicin‐resistant isolates display mutations in three codons rpo B531, 526 and 516 (Campbell et al., 2011; Lipin et al., 2007; Pozzi et al., 1999; Telenti et al., 1993). Similar to that, among the approximately 300 mutations found in the kat G gene, the prevalence of kat G S315T mutation can vary between 32% and 95% in isoniazid‐resistant clinical isolates depending on the geographic regions and drug resistance patterns (Hazbon et al., 2006; Lipin et al., 2007; Mokrousov et al., 2002; Vilcheze & Jacobs, 2014).…”